---
document_datetime: 2023-09-21 19:56:55
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/caelyx-pegylated-liposomal-epar-all-authorised-presentations_en.pdf
document_name: caelyx-pegylated-liposomal-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.3783082
conversion_datetime: 2025-12-15 20:32:56.322647
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name            | Strength   | Pharmace utical Form                  | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|----------------------------|------------|---------------------------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/96/011/001  | Caelyx pegylated liposomal | 2 mg/ml    | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 10 ml                     | 1 vial      |
| EU/1/96/011/002  | Caelyx pegylated liposomal | 2 mg/ml    | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 10 ml                     | 10 vials    |
| EU/1/96/011/003  | Caelyx pegylated liposomal | 2 mg/ml    | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 25 ml                     | 1 vial      |
| EU/1/96/011/004  | Caelyx pegylated liposomal | 2 mg/ml    | Concentrate for solution for infusion | Intravenous use           | vial (glass)          | 25 ml                     | 10 vials    |